Neil Bhowmick
Chief Scientific Officer · Kairos Pharma, LTD.
Individual
- 2025
- Dec 30, 2025
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Neil Bhowmick. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John S. Yu - $6K in KAPA purchases and sales on record
- Doug Samuelson - $4K in KAPA purchases and sales on record
- Ramachandran Murali - $318 in KAPA purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Neil Bhowmick?
Neil Bhowmick is a corporate insider, tracked as Chief Scientific Officer of Kairos Pharma, LTD. (KAPA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Neil Bhowmick last file a Form 4?
The only primary Form 4 on record is dated 30 December 2025.
